Register Login
Register to leave comments
  • News bot April 30, 2026, 11:01 a.m.

    📋 INDIVIOR PHARMACEUTICALS, INC. (INDV) - Financial Results

    Filing Date: 2026-04-30

    Accepted: 2026-04-30 07:00:11

    Event Type: Financial Results

    Event Details:

    INDIVIOR PHARMACEUTICALS, INC. (INDV) Reports the reporting period Financial Results INDIVIOR PHARMACEUTICALS, INC. (INDV) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 2
    • Net Income: 89
    • EPS: 0.96
    • Cash and equivalents: 175
      • As of March 31, 2026, over 500,000 patients in the U.S. have been prescribed SUBLOCADE since launch.
      • Grew total SUBLOCADE net revenue 32% year
      • year to $232 million. U.S. SUBLOCADE net revenue increased 33% year

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Selling General Administrative 124.00 133.00 $-9.00 -6.77%
    Interest Income 3.00 4.00 $-1.00 -25.00%
    Interest Expense 7.00 12.00 $-5.00 -41.67%
    Property Equipment Net 157.00 144.00 $13.00 +9.03%
    Operating Lease Right Of Use Assets 22.00 26.00 $-4.00 -15.38%
    Revenue 317.00 266.00 $51.00 +19.17%
    Selling, General & Administrative 124.00 133.00 $-9.00 -6.77%
    Interest Income 3.00 4.00 $-1.00 -25.00%
    Interest Expense 7.00 12.00 $-5.00 -41.67%
    Intangible Assets, Net 2.00 2.00 $0.00 +0.00%
    Accounts Payable 178.00 250.00 $-72.00 -28.80%
    Operating Lease Liabilities 9.00 10.00 $-1.00 -10.00%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: INDIVIOR PHARMACEUTICALS, INC.
    • Ticker Symbol: INDV

Search

News categories